| Domain |
Quality Indicator |
Facility |
State |
Facility rank
(#1 is best) |
| For the Quality Indicators below, a lower percentage is better. |
| Psychosocial |
Worsening or serious resident behavior problems (LS) |
5.3 % |
8.4 % |
122 of
326 |
| Psychosocial |
Prevalence of depressive symptoms (LS) |
1.0 % |
4.1 % |
75 of
325 |
| Quality of Life |
Prevalence of physical restraints (LS) |
0.0 % |
0.0 % |
1 of
326 |
| Continence |
Worsening or serious bowel incontinence (LS) |
22.9 % |
30.5 % |
67 of
326 |
| Continence |
Worsening or serious bladder incontinence (LS) |
22.7 % |
29.9 % |
99 of
326 |
| Continence |
Prevalence of occasional to full bowel incontinence without a toileting plan (LS) |
100.0 % |
93.9 % |
161 of
314 |
| Continence |
Prevalence of occasional to full bladder incontinence without a toileting plan (LS) |
100.0 % |
84.8 % |
311 of
318 |
| Continence |
Prevalence of indwelling catheter (LS) |
0.0 % |
2.3 % |
1 of
326 |
| Infections |
Prevalence of urinary tract infections (LS) |
4.8 % |
2.9 % |
267 of
326 |
| Infections |
Prevalence of infections (LS) |
2.1 % |
2.4 % |
178 of
324 |
| Accidents |
Percent of residents experiencing one or more falls with major injury (LS) |
1.5 % |
0.7 % |
289 of
326 |
| Nutrition |
Prevalence of unexplained weight loss (LS) |
9.2 % |
4.3 % |
310 of
326 |
| Skin Care |
Prevalence of pressure sores in high risk residents (LS) |
0.0 % |
5.1 % |
1 of
322 |
| Psychotropics |
Prevalence of anti-psychotics without a diagnosis of psychosis (LS) |
13.1 % |
9.0 % |
249 of
321 |
| Functioning |
Worsening or serious functional dependence (LS) |
n/a |
|
n/a of
0 |
| Functioning |
Worsening or serious mobility dependence (LS) |
n/a |
|
n/a of
0 |
| Functioning |
Worsening or serious range of motion limitation (LS) |
17.1 % |
13.2 % |
236 of
323 |
| Pain |
Percent of residents who self-report moderate to severe pain (LS) |
12.8 % |
14.7 % |
144 of
325 |
| For the Quality Indicators below, a higher percentage is better. |
| Functioning |
Walking as well or better than on a previous assessment (LS) |
n/a |
|
n/a of
0 |
| (Date range:
October 1, 2023 to September 30, 2024) |
Contact Us
